RESTASIS (Physicians Total Care, Inc.)


Welcome to the PulseAid listing for the RESTASIS drug offered from Physicians Total Care, Inc.. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Physicians Total Care, Inc.
NON-PROPRIETARY NAME: cyclosporine
SUBSTANCE NAME: CYCLOSPORINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
ROUTE: OPHTHALMIC
DOSAGE FORM: EMULSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-03-27
END MARKETING DATE: 0000-00-00


RESTASIS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRESTASIS from Physicians Total Care, Inc.
LABELER NAME: Physicians Total Care, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/mL)
START MARKETING DATE: 2009-03-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54868-4793_10aaf531-4033-442c-821d-69292ccf5f85
PRODUCT NDC: 54868-4793
APPLICATION NUMBER: NDA050790

Other CYCLOSPORINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Gengraf
Actavis Pharma, Inc.CycloSPORINE
Allergan, Inc.Restasis MultiDose
American Health PackagingCyclosporine
Apotex Corp.Cyclosporine
Cardinal HealthCyclosporine
DR MARC’S MANUFACTURING AND SALESCYCLO-DERM
Eon Labs, Inc.Cyclosporine
IVAX Pharmaceuticals, Inc.Cyclosporine
Mayne Pharma Inc.Cyclosporine
Novartis Pharmaceuticals CorporationSandimmune
Perrigo CompanyCyclosporine
Physicians Total Care, Inc.RESTASIS
Teva Pharmaceuticals USA IncCyclosporine